North Brunswick, NJ, United States of America

Yuguang Wang

USPTO Granted Patents = 14 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 7 (Patent Applications = 1)

Average Co-Inventor Count = 4.7

ph-index = 6

Forward Citations = 269(Granted Patents)

Location History:

East Brunswick, NJ (US) (2004)
North Brunswick, NJ (US) (1999 - 2010)
Monroe, NJ (US) (2009 - 2012)

Company Filing History:

Intervet International B.v.

patents

where one patent can have more than one assignee

Years Active: 1999-2012

Loading Chart...

14 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8153664 - Bicyclic and tricyclic derivatives as thrombin receptor antagonists (2012-04-10),

2. 7897601 - Cannabinoid receptor modulators (2011-03-01),

3. 7888369 - Oxazoloisoquinoline derivatives as thrombin receptor antagonists (2011-02-15),

4. 7713999 - Thrombin receptor antagonists (2010-05-11),

5. 7531544 - Xanthine phosphodiesterase V inhibitors (2009-05-12),

6. 7442712 - Constrained himbacine analogs as thrombin receptor antagonists (2008-10-28),

7. 7304078 - Thrombin receptor antagonists (2007-12-04),

8. 7268141 - Xanthine phosphodiesterase V inhibitors (2007-09-11),

9. 6969719 - Polycyclic guanine phosphodiesterase V inhibitors (2005-11-29),

10. 6831089 - Muscarinic antagonists (2004-12-14),

11. 6821978 - Xanthine phosphodiesterase V inhibitors (2004-11-23),

12. 6043255 - Muscarinic antagonists (2000-03-28),

13. 5977138 - Ether muscarinic antagonists (1999-11-02),

14. 5889006 - Muscarinic antagonists (1999-03-30),

Title: Yuguang Wang: Innovator in Pharmaceutical Chemistry

Introduction

Yuguang Wang is a prominent inventor based in North Brunswick, NJ (US), known for his significant contributions to pharmaceutical chemistry. With a total of 14 patents to his name, he has made remarkable advancements in the field, particularly in the development of therapeutic compounds.

Latest Patents

Among his latest patents, Wang has developed bicyclic and tricyclic derivatives as thrombin receptor antagonists. These compounds are designed to provide therapeutic benefits in various medical conditions. Additionally, he has created cannabinoid receptor modulators, which are useful in treating diseases, disorders, or conditions such as obesity, metabolic disorders, addiction, diseases of the central nervous system, cardiovascular disorders, respiratory disorders, and gastrointestinal disorders.

Career Highlights

Wang has had a successful career, working with notable companies such as Schering Corporation and Intervet Inc. His work has been instrumental in advancing drug development and improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Throughout his career, Wang has collaborated with esteemed colleagues, including Samuel Chackalamannil and Craig D Boyle. These partnerships have contributed to the success of his research and the development of new therapeutic agents.

Conclusion

Yuguang Wang's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a leading inventor in the field. His work continues to impact the development of treatments for various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.